Skip to main content
William Boden, MD, Cardiology, Buffalo, NY

WilliamEBodenMDFACC, FAHA, FASPC

Cardiology Buffalo, NY

Non-Invasive Cardiology, Preventive Cardiology

Scientific Director, Clinical Trials Network, VA Boston Healthcare System; Professor of Medicine, Boston University School of Medicine; Lecturer in Medicine, Harvard Medical School, Boston, Massachusetts

Dr. Boden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Boden's full profile

Already have an account?

  • Office

    100 High St
    Buffalo, NY 14203
    Phone+1 716-859-2260
    Fax+1 716-692-4342

Summary

  • Dr. William E. Boden is Professor of Medicine at Boston University School of Medicine and Lecturer in Medicine, Harvard Medical School, in Boston, Massachusetts. He is the Physician Research Lead for the New England VA Healthcare System and as the Scientific Director of the Clinical Trials Network, which is based at the VA Boston campus. He is also a Senior Investigator at the VA Boston’s Massachusetts Veterans Epidemiology, Research, and Informatics Center (MAVERIC).

    Dr. Boden’s principal research interests include studies in ischemic heart disease, post-MI secondary prevention, acute coronary syndromes, and dyslipidemia in post-MI and coronary artery disease (CAD). Dr. Boden has been involved in clinical research investigator activities as the project director, study chairman and co-chairman for multicenter clinical trials, and served as a principal investigator, steering committee member, and consultant for numerous clinical research grant activities funded by the Department of Veterans Affairs, the NIH, and industry. He was the study chairman for the VANQWISH, INTERCEPT, the landmark COURAGE Trial, and more recently, a national co-PI on the NIH-funded ISCHEMIA Trial.

    Dr. Boden has lectured widely (both nationally and internationally) and has written over 450 peer-reviewed publications, original articles, books, chapters, and abstracts. He has been selected as one of the Best Doctors in America continuously since 2003. He is a member of several professional Cardiology organizations and editorial boards. He is Deputy Editor for the J. Clin. Lipidology, an Associate Editor of the European Heart Journal Journal and a member of the editorial board of Journal of Cardiovascular Pharmacology and Therapeutics. He serves as an adhoc reviewer for many journals including the N. Engl. J. Med., JAMA, JAMA Cardiol., JACC, Circulation, Am. Heart J., the Lancet, Ann. Intern. Med., Am J. Med., and many others

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Cardiovascular Disease, 1977 - 1979
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1974 - 1977
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityClass of 1974

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1997 - 2025
  • VA State Medical License
    VA State Medical License 2011 - 2012
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Best Doctors in America 2015
  • FAHA American Heart Association, 2006
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Sex with Severity of CAD, Ischemia, and Symptom Burden in Patients with Moderate or Severe Ischemia  
    Michael H Picard, Raymond Y Kwong, William E Boden, David J Maron, Judith S Hochman, JAMA Cardiology

Abstracts/Posters

  • [Board 372] Association Between Low Baseline Testosterone Levels and Adverse Clinical Outcomes in Men With Established Cardiovascular Disease in the Atherothrombosis I...
    William Boden, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019

Lectures

  • The Case for Optimal Medical Therapy First in Most! 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
  • Conservative Management Is Appropriate for Most Elderly Patients With NSTEMI 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Increased Residual Cardiovascular Risk in US Veterans and Monerately-Elevated Baseline Triglycerides and Well-Controlled LDL-C Levels on Statins 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Join now to see all

Authored Content

  • ACCEL Lite: What Does a Cardiologist Need To Know About Chronic Kidney Disease?June 2023
  • Letter by Boden Regarding Article, “Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials”April 2020
  • Association of Sex with Severity of CAD, Ischemia, and Symptom Burden in Patients with Moderate or Severe IschemiaMarch 2020

Press Mentions

  • Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE
    Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRESeptember 23rd, 2024
  • Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced
    Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the UnconvincedSeptember 20th, 2024
  • Icosapent Ethyl’s CV Mortality Benefit Magnified in Patients with Prior MI
    Icosapent Ethyl’s CV Mortality Benefit Magnified in Patients with Prior MIApril 25th, 2022
  • Join now to see all

Professional Memberships